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Quantifying the dose of an arbovirus transmitted by
mosquitoes is essential for designing pathogenesis studies
simulating natural infection of vertebrates. Titration of sali-
va collected in vitro from infected mosquitoes may not
accurately estimate titers transmitted during blood feeding,
and infection by needle injection may affect vertebrate
pathogenesis. We compared the amount of Venezuelan
equine encephalitis virus collected from the saliva of Aedes
taeniorhynchus to the amount injected into a mouse during
blood feeding. Less virus was transmitted by mosquitoes in
vivo (geometric mean 11 PFU) than was found for compa-
rable times of salivation in vitro (mean saliva titer 74 PFU).
We also observed slightly lower early and late viremia titers
in mice that were needle injected with 8 PFU, which repre-
sents the low end of the in vivo transmission range. No dif-
ferences in survival were detected, regardless of the dose
or infection route.
D
esigning pathogenesis studies for arboviruses that
accurately simulate natural infection requires quanti-
fying the amount of virus transmitted. Virus assays on
mosquito saliva can be used to estimate the amount trans-
mitted to vertebrates during blood feeding. However,
amount of virus collected in vitro may not accurately
reflect mosquito transmission.
Indirect and direct methods can be used to quantify
virus delivered in mosquito saliva. Indirect methods
include comparing times of death of animals exposed to a
mosquito bite with those infected parenterally with known
doses and comparing the time between mosquito feeding
and development of viremia with the time between needle
injection and development of the same viremia level.
Direct methods include quantifying virus salivated into
drops of blood, virus detected in vertebrate tissues imme-
diately after mosquito feeding, virus salivated into blood
agar, and virus salivated into fluids such as oil. Saliva col-
lection in oil-filled capillary tubes, first described by
Hurlbut (1), is widely used. Chamberlain et al. (2) com-
pared several indirect and direct methods for quantifying
arbovirus transmission and concluded that allowing mos-
quitoes to feed on serum (similar to the capillary method)
is less efficient in detecting virus than other methods.
Since most saliva is expectorated during probing, saliva-
tion into hanging drops or capillary tubes may be inaccu-
rate because mosquitoes do not need to salivate to locate a
blood vessel.
The amount of several arboviruses transmitted by mos-
quitoes has been estimated by using artificial saliva collec-
tion (1–12). Up to 3 log10 PFU of eastern equine
encephalitis virus is deposited into capillary tubes filled
with oil by the vector Culiseta melanura (9). Capillary col-
lection and real-time reverse transcription (RT)–PCR esti-
mate that Culex pipiens pipiens saliva contains an average
of 4.3 log10 PFU of West Nile virus (WNV), with a range
of 0.5 to 5.3 log10 (8). Recently, we estimated that the epi-
demic Venezuelan equine encephalitis virus (VEEV) vec-
tor,  Aedes (Ochlerotatus)  taeniorhynchus, salivates
0.2–3.2 log10 PFU into oil-filled capillary tubes (12).
Vector saliva enhances infection with many pathogens
(13–18), and mosquito saliva is reported to enhance infec-
tion by some arboviruses. Deer and chipmunks infected
with La Crosse virus by the bite of Ae. (Och.) triseriatus
have higher and longer viremias than animals infected by
needle (19). Mice exposed to uninfected mosquitoes and
injected at the feeding site with Cache Valley virus devel-
op enhanced viremia and seroconversion compared with
unbitten mice or to those co-injected with virus and mos-
quito saliva (20). Mice have higher seroconversion rates to
vesicular stomatitis virus when infected by Ae. triseriatus
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Other studies report no enhancement of arbovirus
infection by vector saliva or feeding. Hamsters infected
with WNV by mosquitoes or needle injections do not dif-
fer in level or duration of viremia, clinical manifestations,
pathology, or antibody response (23). Birds infected with
western equine encephalitis virus or Saint Louis encephali-
tis virus by mosquito bite or needle exhibit no difference in
viremia responses (24), and mosquito saliva inhibits in
vitro infection of dendritic cells by dengue virus (25).
VEEV (family  Togaviridae, genus Alphavirus) is an
important emerging and reemerging pathogen of humans
and equines in the neotropics. Since no effective antiviral
agents or a licensed human vaccine for VEEV exists, ther-
apy is primarily supportive and prevention relies on avoid-
ance of mosquitoes. Outbreaks of VEE can involve
hundreds of thousands of equine and human cases, spread
over large regions, and can last several years (26).
The effect of vector feeding on vertebrate infections by
VEEV has not been studied. We determined the amount of
VEEVin mosquito saliva collected in vitro (12) but did not
determine whether this amount accurately reflects trans-
mission during blood feeding. To collect saliva in a capil-
lary tube, we need to subject the mosquito to traumatic
manipulations that may affect salivation, such as anestheti-
zation or immobilization by removal of the legs and wings.
Also, mosquitoes are usually allowed to salivate into cap-
illary tubes for a longer time (e.g., 30 minutes) than is
required for engorgement on a host. Because knowing the
infectious dose transmitted by mosquitoes is important for
designing vertebrate infection studies, in which needles are
typically used for virus delivery, we compared the amount
of VEEV transmitted by mosquitoes in vitro with that
transmitted in vivo. We also determined whether mosquito
transmission affects viremia or time to death when com-
pared with needle infections. Finally, we used tail amputa-
tions to investigate the extravascular or intravascular
location of VEEV deposition during mosquito feeding.
Methods
Virus
We used VEEV rescued from an infectious cDNAclone
derived from epidemic strain 3908 (subtype IC), a 1995
human isolate from Zulia State, Venezuela (27). With the
exception of some IE virus strains in Mexico, subtype IC
viruses are the etiologic agents of all recent VEE epi-
demics. Strain 3908 was passaged once in C6/36 mosqui-
to cells before isolation of viral RNA and production of
infectious cDNA. Virus recovered from baby hamster kid-
ney cells electroporated with transcribed RNA was used
for all experiments. Use of virus derived from an infec-
tious clone minimized attenuating mutations that occur
when VEEV is passaged in cell culture (28).
Mosquitoes
Ae. taeniorhynchus F1 progeny of mosquitoes captured
in Florida (29) were reared at 27°C and a relative humidi-
ty of 80% in a light:dark cycle of 12:12 hours. Adult
females were infected intrathoracically with 4 log10 PFU of
VEEV in a 1-µL volume 6–8 days after emergence and
incubated at 27°C for 5 days with 10% sucrose provided ad
libitum. Intrathoracic infection of mosquitoes with VEEV
and incubation for 5 days generates saliva titers compara-
ble to those that occur after oral infection (12).
In Vivo Transmission
Thirty-nine 6- to 8-week-old National Institutes of
Health (NIH) Swiss mice (Harlan, Indianapolis, IN, USA)
were anesthetized with pentobarbital, and the distal portion
of the tail was exposed to 1 infected mosquito. After mos-
quito engorgement, the tips of the tails of 29 mice were
severed and immediately homogenized in 300 µLo f
Eagle’s minimal essential medium (MEM) supplemented
with 20% fetal bovine serum (FBS) in a Mixer Mill 300
(Retsch Inc., Newton, PA, USA); the tails of 10 control
mice were left intact. After centrifugation at 9,000×g for 5
minutes, the supernatant was removed for cell culture
assays and RNA extraction with a Qiagen kit (Qiagen,
Valencia, CA, USA). Vero cells were injected with 30 µL
of supernatant and observed for 5 days for cytopathic
effects (CPEs). All CPE-positive samples were titrated by
plaque assay on Vero cells. 
RNA was also extracted from the pellet of the tail
homogenate with Trizol (Invitrogen, Carlsbad, CA, USA).
The RNA of both supernatant and tail pellet was tested for
VEEV positive-strand RNA by using real-time RT-PCR
with a one-step kit (Qiagen) and a Smart Cycler (Cepheid,
Sunnyvale, CA, USA). Forward (5′-CATAGTCTAGTC-
CGCCAAGATGTT-3′) and reverse (5′-CGATAGGGC-
ATT GGCTGCAT-3′) primers and a probe (5′-[6-FAM]
CCCGTTCCAACCAATGTAT[NFQ-MGB]-3′) were used
for amplification and detection, respectively. The assay
consisted of reverse transcription at 50°C for 20 minutes,
denaturation at 95°C for 10 minutes, and 45 cycles at 95°C
for 15 seconds, 63°C for 30 seconds, and 72°C for 30 sec-
onds. Virus titers were extrapolated from RT-PCR results
by comparison with a standard curve generated from seri-
al dilutions of a VEEV stock quantified by plaque assay.
After a mosquito probed or fed on the mouse tail, its
infection was confirmed by using forced salivation into a
capillary tube as described below. All 39 mice used were
kept in individual cages, monitored for signs of infection,
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sion by using plaque-reduction neutralization tests.
To ensure that all virus injected into mouse tails could
be recovered and detected, a series of known doses (2.9
log10, 2 log10, and 1 log10 PFU) was injected intradermally
into the tail of a mouse. The tips were then severed and
processed as described above. Each dose was tested in
duplicate, and nearly all the injected virus was recovered
(mean 2.7 log10 PFU recovered for 2.9 log10 inoculum,
mean 1.9 log10 PFU recovered for 2.0 log10 inoculum, and
mean 0.8 log10 PFU recovered for 1.0 log10 inoculum).
Samples with known virus titers were also tested to ensure
that freezing and thawing once did not alter virus content.
Saliva Assays
Thirty-nine saliva samples from intrathoracically infect-
ed mosquitoes that fed on a mouse were obtained by immo-
bilization (legs and wings removed) and forced salivation
into 10-µL capillary tubes (VWR International, West
Chester, PA, USA) containing immersion oil (type B,
Cargille Laboratories Inc., Cedar Grove, NJ, USA). After
30–45 minutes, salivation was confirmed by appearance of
bubbles at the tip of the proboscis. An additional cohort of
mosquitoes was allowed to salivate for intervals (repeated
in triplicate) to duplicate times of observed mosquito feed-
ing. The oil-saliva mixture was centrifuged into 100 µLo f
MEM containing 20% FBS and frozen at −80°C; 30 µLwas
then added to Vero cells for detection of CPE. Mosquito
infection was confirmed by assaying triturated bodies and
legs and wings for CPE, followed by plaque assay.
Viremia and Death
Ten 6- to 8-week-old NIH Swiss mice were infected by
either 1 mosquito or intradermal injection into the ear with
either 0.9 or 3.4 log10 PFU, which represented the range of
titers injected by mosquitoes (see below). Five mice from
each cohort of 10 were bled retroorbitally at 12, 24, 36, 48,
72, 96, and 120 hours postinfection, and sera were titrated
by plaque assay. Mice were monitored daily until signs of
encephalitis appeared, after which they were observed 4
times a day to determine time of death. The University of
Texas Medical Branch Institutional Animal Care and Use
Committee approved all experiments.
Statistical Analysis
Log-transformed data were normally distributed,
except for data from RT-PCR assays from mouse tail
homogenate pellets on which 1 mosquito probed (this
group was not compared statistically). One-way analysis
of variance using Tukey’s test for multiple comparisons
and an unpaired t test were used to compare all normally
distributed data with GraphPad Prism 4.0 (GraphPad
Software, San Diego, CA, USA).
Results
In Vivo Versus In Vitro Transmission Titers
To determine whether saliva collection accurately
approximates the amount of VEEV transmitted during a
mosquito bloodmeal, we quantified virus from saliva col-
lected in vitro and virus deposited at sites of in vivo blood
feeding. One mosquito feeding on the distal portion of a
mouse tail transmitted a mean ± standard deviation of 1.1
± 1.0 log10 PFU (11 PFU) as detected in the homogenate
supernatant and 0.8 ± 0.9 log10 PFU (7 PFU) as estimated
by real-time RT-PCR. These amounts were significantly
lower (p<0.001) than the mean ± standard deviation
amount (3.6 ± 1.5 log10 PFU or 4,300 PFU) deposited into
capillary tubes during 30–45 minutes of salivation (Figure
1). However, the time for engorgement (<3 minutes) was
much shorter than the 45 minutes allowed for in vitro sali-
vation. Therefore, we matched times of saliva collection
(range <3 minutes) to the exact engorgement times. Less
VEEV (p<0.05) was still detected after in vivo transmis-
sion than after <3 minutes of in vitro salivation (1.9 ± 1.2
log10 PFU or 74 PFU).
The effect that the time of probing or feeding had on
the titer of virus salivated was analyzed by timed saliva
collections and  mouse tail exposures. The amount of
VEEV collected from mosquitoes that salivated in vitro
for <3 minutes was significantly less than the amount col-
lected from mosquitoes allowed to salivate for 45 minutes
(p<0.0001). However, no significant difference was seen
in the amount transmitted by mosquitoes allowed to com-
pletely engorge compared with mosquitoes allowed to
probe only, without engorgement (p>0.05, 95% confidence
interval −0.8 to 1.5 log10 PFU for the difference in the
mean titers).
To address the possibility that some virus injected by
feeding mosquitoes rapidly binds to or penetrates mouse
cells and therefore is not measured by plaque assay, we also
examined VEEV RNA content in mouse tails. No differ-
ence was detected between mean virus content in the mouse
tail homogenate supernatants assayed by RT-PCR or
plaques (Figure 1). Detection of relatively small amounts of
viral RNA in tail homogenate pellets indicated that almost
all virus remained in the supernatant and that infectious
virus was not underestimated because of rapid penetration
of cells or binding of virus to connective tissue (Figure 1).
Location of VEEV Deposition In Vivo
To assess intravascular versus extravascular locations of
VEEV deposition by mosquitoes, we amputated the distal
portions of mouse tails immediately after engorgement, and
mice were observed for signs of infection. Forty percent
(4/10) of control mice whose tails were not amputated after
mosquito feeding survived compared with 79% (23/29) of
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exact test). No mice that survived developed neutralizing
antibodies. NIH Swiss mice infected with VEEV have a
death rate approaching 100%, which indicates that a sys-
temic VEEV infection did not occur in surviving animals.
This suggested that nearly all saliva and associated virus
were deposited extravascularly and confined to the bite site
by a lack of immediate vascular dissemination. Tail ampu-
tation nearly doubled survival rates by removing this virus
before replication and dissemination.
Virus Transmitted Versus Time of Engorgement
To assess the temporal pattern of virus deposition dur-
ing blood feeding, the amount of VEEV transmitted was
compared with the time required for mosquito engorge-
ment. Figure 2 shows no correlation between feeding time
and amount of VEEV in mouse tails, suggesting that most
virus in saliva was deposited early during probing, with
minimal deposition during engorgement.
Effect on Pathogenesis in Mice Infected 
by Needle Versus Mosquito
To determine whether mosquito saliva affects patho-
genesis of VEEV infection, mice were infected by either
the bite of 1 mosquito or by intradermal needle injection.
Two VEEV doses were used to represent the range of titers
injected during blood feeding (Figure 1). Viremia from
needle injection with a high dose did not differ from that
generated by mosquito transmission (Figure 3). In con-
trast, viremia from a mosquito bite was higher than that
from a needle injection of a low dose for the 12-hour
(p<0.05) and 96-hour (p<0.001) time points. A significant
difference in viremia (p<0.001) was also observed at the
12-hour and 96-hour time points for mice infected by nee-
dle injection of a high dose than infection of a low dose.
No difference was detected in the mean survival times of
mice infected by either mosquito (5.9 ± 0.6 days) or nee-
dle injection with 8 PFU (6.4 ± 0.7days) or 3.4 log10 PFU
(6.3 ± 0.4 days) (Figure 4).
Discussion
Studies with some (19–21) but not all (23,24)
arboviruses suggest that natural infection by mosquito bite
may potentiate arboviral infection compared with par-
enteral infection. Because the effect of mosquito transmis-
sion on infection by VEEV has not been addressed, we
assessed the infectious dose delivered by a natural vector,
Ae. taeniorhynchus, compared with estimated doses from
saliva collections. We also evaluated the effect of mosqui-
to VEEV transmission on pathogenesis in mice.
In Vivo Versus In Vitro Transmission
Our results indicate that Ae. taeniorhynchus transmit
less VEEV in vivo than they deposit into a capillary tube,
even when saliva collection times are matched to engorge-
ment times. We therefore caution against extended times of
saliva collection in capillary tubes because mosquitoes
allowed to salivate for 45 minutes expel more VEEV than
those that salivate for <3 minutes, the approximate maxi-
mum time required for natural engorgement.
Our study also assessed the location of saliva deposi-
tion. As reasoned by Turell et al. (30,31), if an arbovirus
were deposited intravascularly, it would quickly circulate
beyond the bite site and animals with tail amputations
would still become infected and die. Turell et al. reported
that when the tails of suckling mice are exposed to a
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Figure 1. Titers of Venezuelan equine encephalitis virus
(VEEV) transmitted in vitro or in vivo by Aedes tae-
niorhynchus. A, C, and E) Mosquitoes that engorged to
completion (depicted by closed symbols). B, D, and F)
Mosquitoes who probed but did not engorge (depicted by
open symbols). The assay used to determine the virus titer
was either cell culture assay (A and B, depicted by squares)
or real-time reverse transcription–PCR (C and F) of tail
homogenate supernatant (C and D, depicted as triangles) or
pellet (E and F, depicted as circles). The last 2 cohorts (G
and H) represent VEEV titers in saliva of mosquitoes
allowed to salivate for 45 min (G, depicted as +) or for the
same range of times (<3 min) required for mosquitoes to
engorge completely on mouse tails, repeated in triplicate (H,
depicted as ×). Solid horizontal lines indicate means, and
horizontal dashed lines indicate detection limits for the
assays. Symbols below the dashed lines indicate samples
from infected mosquitoes (bodies and legs or wings positive
for cytopathic effects) that were below the limit of detection
for the assay, and numbers indicate the percentages for
these negative samples (column A=36%, B=47%, C=21%,
D=33%, E=57%, F=73%, G=3%, and H=13%). *Denotes
mice that were bitten by a given mosquito that died.VEEV-infected Ae. taeniorhynchus and the tails are ampu-
tated ≤10 minutes later, 31%–37% survive compared with
4% of mice whose tails were not amputated (30). Our
results indicating that the odds of dying are decreased by
≈50% for those whose tails were amputated suggest that
saliva and VEEV are deposited both intravascularly and
extravascularly. This conclusion is slightly different than
that of Turell et al. (30,31), who concluded that mosquitoes
inject most virus extravascularly and only small amounts
intravascularly or that intravascular transmission occurs
only occasionally. An explanation for the differences in
death rates found in our studies and those of Turell et al. is
that they used suckling mice, whereas we used adult mice.
Two of our mice that had been only probed by an infected
mosquito also became infected. Surprisingly, no VEEV
was detected in the tail homogenate of these mice by either
cell culture or RT-PCR. Because the 50% mouse subcuta-
neous lethal dose (LD50) for VEEV strain 3908 adminis-
tered in the tail is 12 PFU (D.R. Smith, unpub. data), which
is greater than the LD50 for injection in the thigh (12) and
an amount detectable by our methods, virus was probably
deposited primarily intravascularly in these 2 animals.
Forty percent of our mice with intact tails survived after
allowing an infected mosquito to engorge. NIH Swiss mice
are highly susceptible to VEEV; death rates are typically
100%. Therefore, our results and those from our previous
study (12), which reported that infected mosquitoes often
deposit <12 PFU of VEEV into capillary tubes, suggest
that systemically infected Ae. taeniorhynchus frequently
transmit little or no virus. In contrast to the 40% survival
rate of mice with intact tails, 100% of mice infected by
mosquito bite at another site died, presumably because of
a difference in the site of virus deposition. The subcuta-
neous LD50 for VEEV strain 3908 administered in the tail
is 12 PFU compared with <1 PFU in the leg (D.R. Smith,
unpub. data). Mosquitoes may deposit different amounts of
virus at different anatomic sites, depending on accessibili-
ty of blood vessels.
Time of Engorgement and Infectious Dose
Transmitted
The amount of VEEV transmitted by Ae.  tae-
niorhynchus did not correlate with time of engorgement.
However, we did not count how many times the mosquito
probed before beginning to engorge. Assuming that most
mosquito saliva is injected during the intradermal probing
period that precedes cannulation of a blood vessel and that
infection of the host correlates with the duration of saliva-
tion during probing, probing frequency could affect trans-
mission outcome and should be investigated.
Effects on VEE Pathogenesis of Infection 
by Needle Versus Mosquito
Because mosquitoes transmit a wide range of arbovirus
doses, we injected mice with 2 doses that represented the
range of VEEV transmitted in vivo. No difference in
viremia was detected between mice infected by a mosquito
than by needle injection of a high dose. However, mice
infected by mosquito bite showed higher viremia titers at
the early (12 hours) and late (96 hours) time points than did
mice infected with a low dose given by needle. Because
mice injected with the high dose also had higher viremia
titers at some time points than did mice in the low-dose
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Figure 3. Viremia in mice infected by 1 mosquito bite or intrader-
mally by needle injection with 2 different doses of Venezuelan
equine encephalitis virus representing the range of doses deliv-
ered during blood feeding (Figure 1). Five animals per cohort were
bled at each time point. Error bars indicate standard deviations.
Figure 2. Amount of Venezuelan equine encephalitis virus trans-
mitted into a mouse tail versus the time required for complete
engorgement. Only samples from mosquitoes that completely
engorged and transmitted detectable virus were included. cohort (Figure 3), the difference in the infection by mosqui-
to bite versus a low-dose injection by needle may indicate
only that some mosquitoes transmitted doses >8 PFU. The
only way to confirm this slight effect of mosquito transmis-
sion on early and late viremia would be to duplicate the
exact distribution of in vivo transmission titers by needle
injections. However, volumes injected by mosquitoes com-
pared with those injected by needles would differ, as would
intradermal sites of deposition. Another approach is to co-
inject mosquito saliva with virus (20,22), but the same vol-
ume and site discrepancies would apply.
Although route (mosquito versus needle) or dose of
VEEV had no detectable effect on death rates (Figure 4),
mosquito transmission enhancement of early viremia titers
could affect subsequent vector infection, and comparable
studies with natural reservoir or amplification hosts are
needed to assess this possibility. In preliminary studies, no
difference in the viremia response of spiny rats was
observed after VEEV infection by needle compared with
mosquito bites (A.S. Carrara and S.C. Weaver, unpub.
data).
Our results agree with reports of little or no enhance-
ment of alphaviral infections by mosquito transmission
(24). In several studies describing enhancement of arbovi-
ral infection by mosquito transmission, multiple mosqui-
toes were allowed to feed and transmit to 1 vertebrate
(19–21), or salivary gland extracts from many mosquitoes
were injected with virus (20,22). Because natural infection
rates of mosquitoes are typically low, simultaneous trans-
mission by >1 vector is probably rare. In addition, virus
amounts injected by needle in these studies may have been
less than the virus amount transmitted by mosquitoes,
which would confound interpretation. Artificial conditions
used for several experiments demonstrating potentiation of
arbovirus infection by mosquito transmission may there-
fore exaggerate the true effect.
Significance for Pathogenesis Studies
In conclusion, Ae. taeniorhynchus transmit less VEEV
in vivo than they deposit in vitro into capillary tubes.
Mosquito transmission of VEEV has little or no effect on
the overall murine viremia profile and none on death. To
design VEE pathogenesis studies that simulate natural
infection, a dose range from 10 PFU to 1,000 PFU is rec-
ommended to simulate mosquitoborne infections. Because
VEEV saliva titers differ among mosquito species (12),
comparable studies should be conducted with other vectors.
Acknowledgments
We thank Charles Fulhorst for statistical advice, Nikos
Vasilakis and Joseph Masterson for technical advice, and Jing
Huang for rearing mosquitoes.
Darci R. Smith was supported by Centers for Disease
Control and Prevention training grant T01/CCT622892. Patricia
V. Aguilar and Lark L. Coffey were supported by the James W.
McLaughlin Fellowship Fund. This research was supported by
National Institutes of Health grants AI 418807 and AI 57156.
Ms Smith is a graduate student at the University of Texas
Medical Branch in Galveston. Her research interests include
mechanisms of arbovirus transmission by mosquitoes and the
pathogenesis of VEEV in both the mosquito vectors and
vertebrate hosts.
References
1. Hurlbut HS. Mosquito salivation and virus transmission. Am J Trop
Med Hyg. 1966;15:989–93.
2.  Chamberlain RW, Kissling RE, Sikes RK. Studies on the North
American arthropod-borne encephalitides. VII. Estimation of amount
of eastern equine encephalitis virus inoculated by infected Aedes
aegypti. Am J Hyg. 1954;60:286–91.
3. Aitken TH. An in vitro feeding technique for artificially demonstrat-
ing virus transmission by mosquitoes. Mosquito News.
1977;37:130–3.
4. Collins WE. Transmission of Semliki Forest virus by Anopheles albi-
manus using membrane feeding techniques. Mosquito News.
1963;23:96–9.
5. Gubler DJ, Rosen L. A simple technique for demonstrating transmis-
sion of dengue virus by mosquitoes without the use of vertebrate
hosts. Am J Trop Med Hyg. 1976;25:146–50.
6. Mellink JJ. Transmission of Venezuelan equine encephalomyelitis
virus by Aedes aegypti (Diptera: Culicidae) to mice previously
exposed to vector antigens. J Med Entomol. 1982;19:371–5.
7. Ross RW. Alaboratory technique for studying the insect transmission
of animal viruses, employing a bat-wing membrane, demonstrated
with two African viruses. J Hyg (Lond). 1956;54:192–200.
Venezuelan Equine Encephalitis Virus
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 12, No. 8, August 2006 1195
Figure 4. Survival of cohorts of 10 mice infected with Venezuelan
equine encephalitis virus either by 1 mosquito bite or by intrader-
mal needle injection with 2 doses representing the range of virus
titers delivered during mosquito blood feeding (Figure 1).8. Vanlandingham DL, Schneider BS, Klingler K, Fair J, Beasley D,
Huang J, et al. Real-time reverse transcriptase-polymerase chain
reaction quantification of West Nile virus transmitted by Culex pipi-
ens quinquefasciatus. Am J Trop Med Hyg. 2004;71:120–3.
9.  Weaver SC, Scott TW, Lorenz LH. Patterns of eastern equine
encephalomyelitis virus infection in Culiseta melanura (Diptera:
Culicidae). J Med Entomol. 1990;27:878–91.
10. Ross RW. Transmission experiments with chikungunya A and B
virus. Experiments using a new apparatus. Entebbe, Uganda: Virus
Research Institute; 1953. p. 13–14.
11. Davis NC. Attempts to determine the amount of yellow fever virus
injected by the bite of a single infected Stegomyia mosquito.
American Journal of Tropical Medicine. 1934;14:343–54.
12. Smith DR, Carrara A, Aguilar P, Weaver SC. Evaluation of methods
to assess transmission potential of Venezuelan equine encephalitis
virus by mosquitoes and estimation of mosquito saliva titers. Am J
Trop Med Hyg. 2005;73:33–9.
13. Titus RG, Ribeiro JM. Salivary gland lysates from the sand fly
Lutzomyia longipalpis enhance  Leishmania infectivity. Science.
1988;239:1306–8.
14. Shaw MK, Tilney LG, McKeever DJ. Tick salivary gland extract and
interleukin-2 stimulation enhance susceptibility of lymphocytes to
infection by Theileria parva sporozoites. Infect Immun.
1993;61:1486–95.
15. Ribeiro JM. Role of saliva in blood-feeding by arthropods. Annu Rev
Entomol. 1987;32:463–78.
16. Nuttall PA, Jones LD, Labuda M, Kaufman WR. Adaptations of
arboviruses to ticks. J Med Entomol. 1994;31:1–9.
17. Titus RG, Ribeiro JM. The role of vector saliva in transmission of
arthropod-borne disease. Parasitol Today. 1990;6:157–60.
18. Theodos CM, Titus RG. Salivary gland material from the sand fly
Lutzomyia longipalpis has an inhibitory effect on macrophage func-
tion in vitro. Parasite Immunol. 1993;15:481–7.
19. Osorio JE, Godsey MS, Defoliart GR, Yuill TM. La Crosse viremias
in white-tailed deer and chipmunks exposed by injection or mosqui-
to bite. Am J Trop Med Hyg. 1996;54:338–42.
20. Edwards JF, Higgs S, Beaty BJ. Mosquito feeding-induced enhance-
ment of Cache Valley virus (Bunyaviridae) infection in mice. J Med
Entomol. 1998;35:261–5.
21. Limesand KH, Higgs S, Pearson LD, Beaty BJ. Potentiation of vesic-
ular stomatitis New Jersey virus infection in mice by mosquito sali-
va. Parasite Immunol. 2000;22:461–7.
22. Schneider BS, Soong L, Zeidner NS, Higgs S. Aedes aegypti salivary
gland extracts modulate anti-viral and TH1/TH2 cytokine responses
to Sindbis virus infection. Viral Immunol. 2004;17:565–73.
23. Sbrana E, Tonry JH, Xiao SY, da Rosa AP, Higgs S, Tesh RB. Oral
transmission of West Nile virus in a hamster model. Am J Trop Med
Hyg. 2005;72:325–9.
24. Reisen WK, Chiles RE, Kramer LD, Martinez VM, Eldridge BF.
Method of infection does not alter response of chicks and house
finches to western equine encephalomyelitis and St. Louis encephali-
tis viruses. J Med Entomol. 2000;37:250–8.
25. Ader DB, Celluzzi C, Bisbing J, Gilmore L, Gunther V, Peachman
KK, et al. Modulation of dengue virus infection of dendritic cells by
Aedes aegypti saliva. Viral Immunol. 2004;17:252–65.
26. Weaver SC, Ferro C, Barrera R, Boshell J, Navarro JC. Venezuelan
equine encephalitis. Annu Rev Entomol. 2004;49:141–74.
27.  Weaver SC, Salas R, Rico-Hesse R, Ludwig GV, Oberste MS,
Boshell J, et al. Re-emergence of epidemic Venezuelan equine
encephalomyelitis in South America. VEE Study Group. Lancet.
1996;348:436–40.
28. Bernard KA, Klimstra WB, Johnston RE. Mutations in the E2 glyco-
protein of Venezuelan equine encephalitis virus confer heparan sul-
fate interaction, low morbidity, and rapid clearance from blood of
mice. Virology. 2000;276:93–103.
29. Coffey LL, Weaver SC. Susceptibility of Ochlerotatus tae-
niorhynchus and Culex nigripalpus for Everglades virus. Am J Trop
Med Hyg. 2005;73:11–6.
30. Turell MJ, Spielman A. Nonvascular delivery of Rift Valley fever
virus by infected mosquitoes. Am J Trop Med Hyg. 1992;47:190–4.
31. Turell MJ, Tammariello RF, Spielman A. Nonvascular delivery of St.
Louis encephalitis and Venezuelan equine encephalitis viruses by
infected mosquitoes (Diptera: Culicidae) feeding on a vertebrate host.
J Med Entomol. 1995;32:563–8.
Address for correspondence: Scott C. Weaver, Department of Pathology,
University of Texas Medical Branch, 301 University Blvd, Galveston, TX
77555-0609, USA; email: sweaver@utmb.edu
RESEARCH
1196 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 12, No. 8, August 2006
Search
past issues